Keywords: سندرم اورمیک همولیتیک آتیپیک; Posterior reversible encephalopathy syndrome; Cerebellar; Hydrocephalus; Atypical hemolytic uremic syndrome; Macrophage activation syndrome;
مقالات ISI سندرم اورمیک همولیتیک آتیپیک (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: سندرم اورمیک همولیتیک آتیپیک; ADAMTS13; disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13; aHUS; atypical hemolytic uremic syndrome; BU; Bethesda units; CF; complement factor; CFHR; complement factor H-related; HUS; hemolytic uremic syndrome; iTTP; auto
Keywords: سندرم اورمیک همولیتیک آتیپیک; Thrombotic microangiopathy; Pregnancy; Preeclampsia with severe features; HELLP (hemolysis, Elevated liver enzymes, Low platelet count syndrome); Atypical hemolytic uremic syndrome;
Keywords: سندرم اورمیک همولیتیک آتیپیک; acute fatty liver of pregnancy; acute kidney injury; atypical hemolytic uremic syndrome; preeclampsia; pregnancy; pyelonephritis;
Keywords: سندرم اورمیک همولیتیک آتیپیک; aHUS; atypical hemolytic uremic syndrome; AP; alternative pathway; C3; complement component 3; C5; complement component 5; C3G; C3 glomerulopathy; CFB; complement factor B; CFH; complement factor H; CFI; complement factor I; COMS; complement serology pane
Keywords: سندرم اورمیک همولیتیک آتیپیک; ADA; anti-drug antibodies; AMPK; 5â² adenosine monophosphate-activated protein kinase; aHUS; atypical hemolytic uremic syndrome; AMD; age-related macular degeneration; APC; antigen presenting cells; AT; anaphylatoxin; BTK; Bruton's tyrosine kinase; C1q
Keywords: سندرم اورمیک همولیتیک آتیپیک; Complement; Paroxysmal Nocturnal Hemoglobinuria; Atypical Hemolytic Uremic Syndrome;
Keywords: سندرم اورمیک همولیتیک آتیپیک; Atypical hemolytic uremic syndrome; Thrombotic microangiopathies; Complement activation; Eculizumab;
Keywords: سندرم اورمیک همولیتیک آتیپیک; Atypical hemolytic uremic syndrome; Complement; Eculizumab; Terminal complement inhibitor; Thrombotic microangiopathy; AH50; Alternative pathway function; TMA; Thrombotic microangiopathy; HUS; Hemolytic uremic syndrome; aHUS; Atypical HUS; LDH; Lactate de
Keywords: سندرم اورمیک همولیتیک آتیپیک; Alternative pathway of complement; Paroxysmal nocturnal hemoglobinuria; Atypical hemolytic uremic syndrome; HELLP syndrome; Cold agglutinin disease; Complementopathy;
Keywords: سندرم اورمیک همولیتیک آتیپیک; Genetics; glomerular diseases; atypical hemolytic uremic syndrome; complement; membranoproliferative glomerulonephritis; lupus nephritis; IgA nephropathy;
Keywords: سندرم اورمیک همولیتیک آتیپیک; Alternative complement pathway dysregulation; Atypical hemolytic uremic syndrome; C3 glomerulopathy; Eculizumab;
Keywords: سندرم اورمیک همولیتیک آتیپیک; Atypical hemolytic uremic syndrome; Eculizumab; Efficacy; Safety; Quality of life;
Keywords: سندرم اورمیک همولیتیک آتیپیک; alternative pathway; atypical hemolytic uremic syndrome; C3Â glomerulonephritis; C3 glomerulopathy; classical pathway; complement; dense-deposit disease; glomerulonephritis;
Keywords: سندرم اورمیک همولیتیک آتیپیک; Thrombotic microangiopathy; Atypical hemolytic uremic syndrome; Alternative complement pathway; Eculizumab; Treatment monitoring
Keywords: سندرم اورمیک همولیتیک آتیپیک; atypical hemolytic uremic syndrome; blood outgrowth endothelial cells; complement; thrombotic microangiopathy; thrombotic thrombocytopenic purpura; von Willebrand factor;
Keywords: سندرم اورمیک همولیتیک آتیپیک; Thrombocytopenia; Immune thrombocytopenia; Heparin-induced thrombocytopenia; Thrombotic thrombocytopenia purpura; Atypical hemolytic uremic syndrome;
Keywords: سندرم اورمیک همولیتیک آتیپیک; Acute kidney injury; Pregnancy-related acute kidney injury; Atypical hemolytic uremic syndrome; Thrombotic microangiopathy; Preeclampsia; Hypertensive disorders of pregnancy;
Keywords: سندرم اورمیک همولیتیک آتیپیک; AChR; acetylcholine receptor; aHUS; atypical hemolytic uremic syndrome; AMD; age-related macular degeneration; AMR; antibody-mediated rejection; ANCA; anti-neutrophil cytoplasmic antibody; AP; alternative pathway; C1-INH; C1 esterase inhibitor; C3GN; C3 g
Keywords: سندرم اورمیک همولیتیک آتیپیک; Thrombotic microangiopathy; Atypical hemolytic uremic syndrome; Hemolytic uremic syndrome; Thrombotic thrombocytopenic purpura;
Keywords: سندرم اورمیک همولیتیک آتیپیک; Atypical hemolytic uremic syndrome; eculizumab; discontinuation;
Keywords: سندرم اورمیک همولیتیک آتیپیک; Eculizumab; C3 glomerulopathies; Atypical hemolytic uremic syndrome; Complement; Anti-neutrophil cytoplasmic autoantibody;
Keywords: سندرم اورمیک همولیتیک آتیپیک; Thrombotic thrombocytopenic purpura; Atypical hemolytic uremic syndrome; ADAMTS13; Complement activation; Diagnosis
Keywords: سندرم اورمیک همولیتیک آتیپیک; Atypical hemolytic uremic syndrome; eculizumab; complement; thrombotic microangiopathy;
Keywords: سندرم اورمیک همولیتیک آتیپیک; Atypical hemolytic uremic syndrome; Complement system; Microangiopathic hemolytic anemia; Thrombotic microangiopathy; Thrombotic thrombocytopenic purpura
Keywords: سندرم اورمیک همولیتیک آتیپیک; CVF; cobra venom factor; rCVF; recombinant CVF; hCVF; humanized CVF; MAC; membrane attack complex; PNH; paroxysmal nocturnal hemoglobinuria; MI/RI; myocardial ischemia reperfusion injury; GI/RI; gastrointestinal ischemia reperfusion injury; AMD; age-relat
Keywords: سندرم اورمیک همولیتیک آتیپیک; Atypical hemolytic uremic syndrome; Complement; Acute kidney injury; Thrombocytopenia;
Keywords: سندرم اورمیک همولیتیک آتیپیک; Atypical hemolytic uremic syndrome; Complement; Eculizumab;
Keywords: سندرم اورمیک همولیتیک آتیپیک; Atypical hemolytic uremic syndrome; Complement; Plasma; Eculizumab; Properdin;
Properdin: A multifaceted molecule involved in inflammation and diseases
Keywords: سندرم اورمیک همولیتیک آتیپیک; aHUS; atypical hemolytic uremic syndrome; AAA; abdominal aortic aneurysm; AAV; ANCA-associated vasculitis; AMD; age-related macular degeneration; AMR; antibody-mediated rejection; ANCA; anti-neutrophil cytoplasmic antibody; AP; alternative pathway; APC; a
Alternative pathway activation due to low level of complement factor H in primary antiphospholipid syndrome
Keywords: سندرم اورمیک همولیتیک آتیپیک; aHUS; atypical hemolytic uremic syndrome; aPL; antiphospholipid antibodies; APS; antiphospholipid syndrome; CRF; complement regulatory factors; CTD; connective tissue diseases; ELISA; enzyme-linked immunosorbent assays; FH; factor H; HRP; hydrogen peroxid
Patients with hypertension-associated thrombotic microangiopathy may present with complement abnormalities
Keywords: سندرم اورمیک همولیتیک آتیپیک; atypical hemolytic uremic syndrome; complement dysregulation; genetics; malignant hypertension; thrombotic microangiopathy;
Theranostic of biopharmaceuticals
Keywords: سندرم اورمیک همولیتیک آتیپیک; α3Gal; galactose-α1,3-galactose; ADA; anti-drug antibody; aHUS; atypical hemolytic uremic syndrome; ARIC; ADA-related immune complex; CEP17; centromere of chromosome 17; CCP; cyclic citrullinated peptide; CTLA-4; cytotoxic T-lymphocyte-associated protei
Factor H autoantibody is associated with atypical hemolytic uremic syndrome in children in the United Kingdom and Ireland
Keywords: سندرم اورمیک همولیتیک آتیپیک; acute kidney injury; atypical hemolytic uremic syndrome; complement; factor H autoantibodies; thrombotic microangiopathy;
Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference
Keywords: سندرم اورمیک همولیتیک آتیپیک; anti-complement therapies; atypical hemolytic uremic syndrome; C3 glomerulopathy; complement; glomerulonephritis; kidney disease;
Controlling the anaphylatoxin C5a in diseases requires a specifically targeted inhibition
Keywords: سندرم اورمیک همولیتیک آتیپیک; Complement activation; C5a blockade; Trypsin; Thrombin; Eculizumab; aHUS; atypical hemolytic uremic syndrome; APH50; 50% haemolytic complement activity of alternative pathway; C3N; C3 glomerulonephritis; CH50; 50% haemolytic complement activity of classic
Novel biomarker and easy to perform ELISA for monitoring complement inhibition in patients with atypical hemolytic uremic syndrome treated with eculizumab
Keywords: سندرم اورمیک همولیتیک آتیپیک; Atypical hemolytic uremic syndrome; Thrombotic microangiopathies; Complement activation; Terminal complement complex; Eculizumab;
Syndrome hémolytique et urémique atypique confondu avec un syndrome de Goodpasture : à propos d’un cas
Keywords: سندرم اورمیک همولیتیک آتیپیک; Anticorps anti-MBG; Échanges plasmatiques; Éculizumab; Hémorragie intra-alvéolaire; Syndrome hémolytique et urémique atypique; Syndrome pneumo-rénalAnti-GBM antibodies; Atypical hemolytic uremic syndrome; Eculizumab; Intra-alveolar hemorrhage; Plasma exch
The molecular and structural bases for the association of complement C3 mutations with atypical hemolytic uremic syndrome
Keywords: سندرم اورمیک همولیتیک آتیپیک; AP; alternative pathway; aHUS; atypical hemolytic uremic syndrome; CP; classical pathway; CR1; complement receptor 1; DAF; decay accelerating factor; DDD; dense deposit disease; EM; electron microscopy; FB; factor B; FD; factor D; FH; factor H; FI; factor
Complement factor H, FHR-3 and FHR-1 variants associate in an extended haplotype conferring increased risk of atypical hemolytic uremic syndrome
Keywords: سندرم اورمیک همولیتیک آتیپیک; aHUS; atypical hemolytic uremic syndrome; AMD; age-related macular degeneration; ANOVA; analysis of variance; C3; complement component 3; C3; C3 gene; C3G; C3-glomerulopathy; C4; complement component 4; C4; C4 gene; CGH; comparative genomic hybridization;
Autoantibodies to complement components in C3 glomerulopathy and atypical hemolytic uremic syndrome
Keywords: سندرم اورمیک همولیتیک آتیپیک; Autoantibodies; Kidney disease; Atypical hemolytic uremic syndrome; C3 glomerulopathy; Complement regulation; C3 convertase; Factor B; Factor H; C3 nephritic factor
Review articleThe endothelial glycocalyx as a potential modifier of the hemolytic uremic syndrome
Keywords: سندرم اورمیک همولیتیک آتیپیک; Glycocalyx; Heparan sulfate proteoglycan; Complement factor H; Thrombomodulin; Atypical hemolytic uremic syndrome;
Untying the Knot of Thrombotic Thrombocytopenic Purpura and Atypical Hemolytic Uremic Syndrome
Keywords: سندرم اورمیک همولیتیک آتیپیک; ADAMTS13; Atypical hemolytic uremic syndrome; Complement regulation; Microangiopathic hemolytic anemia; Thrombotic thrombocytopenic purpura
Treatment of Atypical Hemolytic Uremic Syndrome and Thrombotic Microangiopathies: A Focus on Eculizumab
Keywords: سندرم اورمیک همولیتیک آتیپیک; Thrombotic microangiopathy; complement; atypical hemolytic uremic syndrome; eculizumab;
Thrombotic Thrombocytopenic Purpura and the Atypical Hemolytic Uremic Syndrome
Keywords: سندرم اورمیک همولیتیک آتیپیک; Thrombotic thrombocytopenic purpura; Atypical hemolytic uremic syndrome; Microangiopathic hemolysis; Shear stress; ADAMTS13; Complement regulators;
Eculizumab in the Treatment of Atypical Hemolytic Uremic Syndrome in Infants
Keywords: سندرم اورمیک همولیتیک آتیپیک; Atypical hemolytic uremic syndrome; eculizumab; infant;
Contribution of complement factor H Y402H polymorphism to sudden sensorineural hearing loss risk and possible interaction with diabetes
Keywords: سندرم اورمیک همولیتیک آتیپیک; aHUS; atypical hemolytic uremic syndrome; AMD; age-related macular degeneration; CFH; complement factor H; CI; confidence interval; CRP; C-reactive protein; MPGN2; membranoproliferative glomerulonephritis type II; NILS-LSA; National Institute for Longevit
ZespóÅ hemolityczno-mocznicowy u dzieci w latach 1971-2010; doÅwiadczenia jednego oÅrodka dializ dla dzieci
Keywords: سندرم اورمیک همولیتیک آتیپیک; zespóÅ hemolityczno-mocznicowy; atypowy zespóÅ hemolityczno-mocznicowy; plazmafereza; ostra niewydolnoÅÄ nerek; hemolytic uremic syndrome; atypical hemolytic uremic syndrome; plasmapheresis; acute renal failure;
Apport de l'immunologie au diagnostic en néphrologie : actualités en 2012
Keywords: سندرم اورمیک همولیتیک آتیپیک; Syndrome hémolytique et urémique atypique; déficit du complément; glomérulonéphrite extra-membraneuse; anticorps anti-PLA2R; syndrome d'hyper IgG4; Atypical hemolytic uremic syndrome; complement deficiency; membranous nephropathy; anti-PLA2R antib
Alternative complement pathway assessment in patients with atypical HUS
Keywords: سندرم اورمیک همولیتیک آتیپیک; Atypical Hemolytic Uremic Syndrome; Complement; Complement blockers; Factor H; C3 convertase; Defective complement regulators;